DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Busse W. et al.
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
The Journal of allergy and clinical immunology 2001;
108 (02) 184-190
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.